Tert-Butylamine is a chemically defined substance encountered in pharmaceutical manufacturing whose health-based exposure limit derivation requires integration of pharmacological, toxicokinetic, and general toxicological data to identify the most relevant point of departure. The quality and completeness of the toxicological database for Tert-Butylamine directly influences the magnitude of uncertainty factors applied and the confidence in the resulting PDE value. Periodic review of new published data and post-market clinical safety signals ensures that the OEL for Tert-Butylamine remains protective as scientific knowledge develops.
Cleaning validation acceptance criteria for Tert-Butylamine in shared pharmaceutical equipment are determined using the health-based MACO formula: MACO (mg/batch) = PDE(mg/day) × MBS(g) ÷ TDD(g/day), where MBS is the minimum batch size of the next product and TDD its maximum daily therapeutic dose.
